About
About Guangdong Jiaying Pharmaceutical Co., Ltd
Guangdong Jiaying Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese patent medicines in Mainland China. The company offers medicines primarily for the treatment of throat ailments, colds, orthopedics, rheumatism, gynecology, hepatobiliary diseases, tonics, and gastrointestinal disorders. It also provides Shuangliao Houfeng powder, Chongganling tablets, Jiegu Qili tablets (capsules), Xiaoyan Lidan Tablets, and Jinju Wuhua tea, etc., as well as double throat lozenges and tablets, heavy psychotherapy, Yuqiao detoxification granules, orange peel cough granules, bone-setting Qili tablets and capsules, anti-inflammatory and choleretic tablets, chrysanthemum five-flower tea granules, Zhuang Yao Jian Shen pills, Gujing Shenrong pills, Guifuli Zhongwan, and stomach pain tablets. Guangdong Jiaying Pharmaceutical Co., Ltd. was founded in 2003 and is based in Meizhou, China.
Research context
Guangdong Jiaying Pharmaceutical Co., Ltd appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Visit company website
5 years, 6 months ago
Guangdong Jiaying Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 62.1% above its 200 day moving average.
From a valuation standpoint, the stock is 47.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.1.
Guangdong Jiaying Pharmaceutical Co., Ltd's total revenue rose by 19.2% to $147M since the same quarter in the previous year.
Its net income has dropped by 61.3% to $3M since the same quarter in the previous year.
Finally, its free cash flow grew by 305.1% to $14M since the same quarter in the previous year.
Based on the above factors, Guangdong Jiaying Pharmaceutical Co., Ltd gets an overall score of 4/5.